Cancer BiologyCancer ResearchPeer-reviewed
Kinome focused CRISPR-Cas9 screens in African ancestry patient-derived breast cancer organoids identifies essential kinases and synergy of EGFR and FGFR1 inhibition.
F. P. Madorsky Rowdo, R. Martini, S. E. Ackermann…·M. L. Martin
The paper uses CRISPR-Cas9 screens in breast cancer organoids from African ancestry patients to identify essential kinases and show synergy between EGFR and FGFR1 inhibitors.
DOI 10.1158/0008-5472.can-24-0775